Jusvinza treatment resolution in confirmed COVID-19 patients. Santiago de Cuba, 2021

<strong>Foundation</strong>: SARS-CoV-2 infection is the most important emerging disease of this century. In this context, the Cuban Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) created therapeutic alternatives to combat COVID-19, including the use of Jusvinza, which...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Caridad Laurencio Vallina (Author), Martha María Arias Carbonell (Author), Leonardo Ramos Hechavarría (Author), Dayami Lescay Balanquet (Author), Roger Pina Núñez (Author)
Format: Book
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos, 2024-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available